[Federal Register: March 1, 2001 (Volume 66, Number 41)]
[Notices]               
[Page 12938-12939]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01mr01-61]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N-0242]

 
Agency Information Collection Activities; Announcement of OMB 
Approval; Biological Products: Reporting of Biological Product 
Deviations in Manufacturing

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Biological Products: Reporting of 
Biological Product Deviations in Manufacturing'' has been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 7, 2000 
(65 FR 66621), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0458. 
The approval expires on February 29, 2004. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.


[[Page 12939]]


    Dated: February 22, 2001.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 01-4966 Filed 2-28-01; 8:45 am]
BILLING CODE 4160-01-S